pharma · Myotonic Dystrophy Type 1 · Myotonic Dystrophy Type 1 (DM1) · DYN
Dyne Therapeutics
News and analysis for Dyne Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.
Waltham, USA HQ
2018 Founded
276 Employees
Public company Type
DYN · NYSE Ticker
Company details
- Status
- Public
- HQ
- Waltham, USA
- Founded
- 2018
- Employees
- 276
- Programs
- 6
- Drugs
- 11
- Patents
- 82
News & analysis
NovaPharmaNews articles mentioning Dyne Therapeutics — regulatory, clinical, and market coverage.
News and analysis for Dyne Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.